Prof Dr Yusuf Yılmaz
Prof Dr Yusuf Yılmaz
Marmara University, School of Medicine; Institute of Gastroenterology
Verified email at - Homepage
Cited by
Cited by
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ...
Journal of hepatology 73 (1), 202-209, 2020
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
Gastroenterology 158 (7), 1999-2014.e1., 2020
Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Z Younossi, F Tacke, M Arrese, B Chander Sharma, I Mostafa, ...
Hepatology 69 (6), 2672-2682, 2019
Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis
G Musso, R Gambino, JH Tabibian, M Ekstedt, S Kechagias, ...
PLoS medicine 11 (7), e1001680, 2014
Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates
Z Younossi, M Stepanova, JP Ong, IM Jacobson, E Bugianesi, A Duseja, ...
Clinical Gastroenterology and Hepatology 17 (4), 748-755. e3, 2019
Apoptosis: why and how does it occur in biology?
E Ulukaya, C Acilan, Y Yilmaz
Cell biochemistry and function 29 (6), 468-480, 2011
is non‐alcoholic fatty liver disease a spectrum, or are steatosis and non‐alcoholic steatohepatitis distinct conditions?
Y Yilmaz
Alimentary pharmacology & therapeutics 36 (9), 815-823, 2012
FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation …
PN Newsome, M Sasso, JJ Deeks, A Paredes, J Boursier, WK Chan, ...
The lancet Gastroenterology & hepatology 5 (4), 362-373, 2020
Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis
Y Yilmaz, E Dolar, E Ulukaya, S Akgoz, M Keskin, M Kiyici, S Aker, ...
World journal of gastroenterology: WJG 13 (6), 837, 2007
The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
M Eslam, SK Sarin, VWS Wong, JG Fan, T Kawaguchi, SH Ahn, ...
Hepatology international 14 (6), 889-919, 2020
Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease
Y Yilmaz, F Eren, O Yonal, R Kurt, B Aktas, CA Celikel, O Ozdogan, ...
European journal of clinical investigation 40 (10), 887-892, 2010
Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease
Y Yilmaz, O Yonal, R Kurt, YO Alahdab, F Eren, O Ozdogan, CA Celikel, ...
Scandinavian journal of gastroenterology 46 (1), 91-97, 2011
Effects of sitagliptin in diabetic patients with nonalcoholic steatohepatitis
Y Yilmaz, O Yonal, O Deyneli, CA Celikel, C Kalayci, DG Duman
Acta Gastro Enterol. Belg 75, 240-244, 2012
Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year …
I Akdag, Y Yilmaz, S Kahvecioglu, N Bolca, I Ercan, A Ersoy, M Gullulu
Nephron Clinical Practice 108 (2), c99-c105, 2008
Noninvasive assessment of liver fibrosis with the aspartate transaminase to platelet ratio index (APRI): Usefulness in patients with chronic liver disease: APRI in chronic …
Y Yilmaz, RK Oya Yonal, M Bayrak, B Aktas, O Ozdogan
Hepatitis monthly 11 (2), 103, 2011
Microalbuminuria in nondiabetic patients with nonalcoholic fatty liver disease: association with liver fibrosis
Y Yilmaz, YO Alahdab, O Yonal, R Kurt, AE Kedrah, CA Celikel, ...
Metabolism 59 (9), 1327-1330, 2010
Systematic review: caspase‐cleaved fragments of cytokeratin 18–the promises and challenges of a biomarker for chronic liver disease
Y Yilmaz
Alimentary pharmacology & therapeutics 30 (11‐12), 1103-1109, 2009
Assessment of endothelial function in patients with nonalcoholic fatty liver disease
Y Colak, E Senates, A Yesil, Y Yilmaz, O Ozturk, L Doganay, ...
Endocrine 43 (1), 100-107, 2013
Kefir improves the efficacy and tolerability of triple therapy in eradicating Helicobacter pylori
O Bekar, Y Yilmaz, M Gulten
Journal of medicinal food 14 (4), 344-347, 2011
Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease
B Aktas, Y Yilmaz, F Eren, O Yonal, R Kurt, YO Alahdab, CA Celikel, ...
Metabolism 60 (4), 544-549, 2011
The system can't perform the operation now. Try again later.
Articles 1–20